Suchergebnisse - "Ghez, David"

PubPharm (19)

1

Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study

enthalten in: American journal of hematology | 2023

von Michot, J. | Quivoron, C. | Sarkozy, C. | +26

2

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection

enthalten in: Frontiers in immunology | 2023

von Lécuyer, D. | Nardacci, R. | Tannous, D. | +28

3

Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma : Results of LNH-EP1 study

enthalten in: American journal of hematology | 2021

von Sarkozy, C. | Michot, J. | Quivoron, C. | +24

4

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

enthalten in: The New England journal of medicine | 2021

von Kastritis, E. | Palladini, G. | Minnema, M. | +148

CommentIn: Nat Rev Rheumatol. 2021 Sep;17(9):510. - PMID 34345020

5

Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von El Halabi, L. | Adam, J. | Gravelle, P. | +8

6

Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19

enthalten in: Blood | 2020

von Hueso, T. | Pouderoux, C. | Péré, H. | +34

CommentIn: Blood. 2020 Nov 12;136(20):2245-2246. - PMID 33180920

7

Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus

enthalten in: Haematologica | 2020

von Blez, D. | Blaize, M. | Soussain, C. | +8

8

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Brighton, T. | Khot, A. | Harrison, S. | +15

9

Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials

enthalten in: Investigational new drugs | 2018

von Michot, J. | Benajiba, L. | Faivre, L. | +20

10

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia : A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group

enthalten in: American journal of hematology | 2017

von Michallet, A. | Campidelli, A. | Lequeu, H. | +13